13F

Track13F

Track what the world's top investors are buying. SEC 13F filing data from institutional portfolio disclosures, updated quarterly.

I

INNT

Innate Immunotherapeutics

Institutional holders

0

Total 13F value

$0

Sum of disclosed positions

New positions

0

This quarter

Sold positions

0

This quarter

Top holders

Institutions with disclosed positions in this stock

No holders available yet.

INNT — Who Owns Innate Immunotherapeutics | Track13F | Track13F